Ignite Creation Date:
2025-12-24 @ 7:07 PM
Ignite Modification Date:
2025-12-25 @ 4:40 PM
Study NCT ID:
NCT05738057
Status:
RECRUITING
Last Update Posted:
2023-11-29
First Post:
2023-02-14
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Combined Therapy Using D-TACE, Gemcitabine and Cisplatin, and PD1 Antibody in Advanced and Unresectable Intrahepatic Cholangiocarcinoma
Sponsor:
Hua Li
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-06-30
Start Date Type:
ACTUAL
Primary Completion Date:
2025-03-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-03-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-02-14
First Submit QC Date:
None
Study First Post Date:
2023-02-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-11-22
Last Update Post Date:
2023-11-29
Last Update Post Date Type:
ACTUAL